Business of the Issuer. The Administrator agrees to carry out and perform the day to day business activities (as set forth in Section 2.2 hereof) of the Issuer in the name and on behalf of the Issuer as its agent.
Business of the Issuer. Since the date of incorporation of the Issuer there has been no material adverse change in the financial position of the Issuer;
Business of the Issuer. The Issuer is not engaged principally, or as one of its important activities, in the business of extending credit for the purpose of purchasing or carrying any margin stock as defined in Regulation U of the Board of Governors of the Federal Reserve System.
Business of the Issuer. The Issuer has not (i) conducted any business as of the Closing Date, (ii) entered into or incurred any contractual obligations or (iii) subjected itself to any regulatory requirements, other than, in each case, as contemplated by, or resulting from entering into, the Transaction Documents.
Business of the Issuer. The Issuer shall (i) administer the Business with due care and (ii) maintain (a) all licenses and permits necessary to perform the administration of the Business, (b) all material data related to the administration of the Business in a form consistent with prudent industry standards and in accordance with the Administration Services Agreement and (c) all administrative systems related to the Business with appropriate security, business continuity testing, data retention and other internal controls consistent with prudent industry standards. The Issuer shall not, without the prior written consent of the Required Noteholders (1) assign or otherwise attempt to assign or transfer the Business to another Person or (2) engage in or acquire any new business, whether administrative or otherwise, unrelated to the Business. The Issuer shall not engage in any transaction unless the terms of such transaction are on an “arm’s length” commercial basis with any other party to such transaction.
Business of the Issuer. Odyssey was formed as a publicly held holding company with an emphasis on the development and acquisition of medical products and health related technologies. We are focused on building and acquiring assets in areas that have an identified technological advantage and a substantial market opportunity within significant target markets across the globe. Before making an investment decision, you should carefully consider the business of the Company as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2020, as amended from time to time, which is incorporated herein by reference, or any updates in our Quarterly Reports on Form 10-Q, together with all of the other information appearing in or incorporated by reference into this prospectus and any applicable prospectus supplement, in light of your particular investment objectives and financial circumstances.
Business of the Issuer. There is a cessation of or material change to the nature or scope of the business and operations of the Issuer as carried on by the Issuer as at the date of this Agreement.
Business of the Issuer. The Issuer covenants and agrees to not engage at any time in any business or business activity other than a Permitted Business.
Business of the Issuer. EMPLOYEES AND SUBCONTRACTORS; OFFICES
SECTION 3.1. BUSINESS OF THE ISSUER...........................................9 SECTION 3.2. EMPLOYEES AND SUBCONTRACTORS.....................................9
Business of the Issuer. The Issuer will not own any asset or property other than the Mortgaged Properties. The Issuer will not engage in any business other than the ownership of the Mortgaged Properties and the Issuer will conduct and operate its business as presently conducted and operated.
